BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23520767)

  • 1. [Allosteric modulator of GPCRs and new drug targets].
    Wei RS; He SP
    Sheng Li Ke Xue Jin Zhan; 2012 Dec; 43(6):459-62. PubMed ID: 23520767
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA; Pantel J
    Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
    Ortiz Zacarías NV; Lenselink EB; IJzerman AP; Handel TM; Heitman LH
    Trends Pharmacol Sci; 2018 Jun; 39(6):547-559. PubMed ID: 29653834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-protein-coupled receptor pharmacology: examining the edges between theory and proof.
    Gilchrist A; Blackmer T
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):446-51. PubMed ID: 17659486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D; Miller LJ
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacological effect of allosteric regulation at GPCR heterodimer].
    Zhang N; Chen J; Gong L; Liu LL; Bai B
    Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):93-8. PubMed ID: 23847918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light- and drug-activated G-protein-coupled receptors to control intracellular signalling.
    Masseck OA; Rubelowski JM; Spoida K; Herlitze S
    Exp Physiol; 2011 Jan; 96(1):51-6. PubMed ID: 21041315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
    Lewis JA; Lebois EP; Lindsley CW
    Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [G-protein-coupled receptors, the beginning of a new era for therapeutic innovation].
    Bril A; Combettes M; Audinot V
    Med Sci (Paris); 2012 Oct; 28(10):799-800. PubMed ID: 23067404
    [No Abstract]   [Full Text] [Related]  

  • 14. [G protein-coupled receptors: allosteric regulators of cell metabolism].
    Galzi JL; Ilien B
    Med Sci (Paris); 2012 Oct; 28(10):852-7. PubMed ID: 23067416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications.
    Wold EA; Zhou J
    Curr Top Med Chem; 2018; 18(23):2002-2006. PubMed ID: 30621563
    [No Abstract]   [Full Text] [Related]  

  • 18. New concepts in drug discovery: collateral efficacy and permissive antagonism.
    Kenakin T
    Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand detection in the allosteric world.
    Kenakin TP
    J Biomol Screen; 2010 Feb; 15(2):119-30. PubMed ID: 20086210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.